ClinicalTrials.gg
CompletedNCT01135888Updated Aug 19, 2021

Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia

An observational study in X-Linked Hypohidrotic Ectodermal Dysplasia and Exercise-induced Rise of Body Temperature, sponsored by University Hospital Erlangen. Completed at 1 site in Germany. Open to male participants aged 7 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-19.

Sponsored by University Hospital Erlangen · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
28
Ages
7 Years to 18 Years
Sex
Male
01

Study summary

Because of their lack of sweat glands individuals with hypohidrotic ectodermal dysplasia (HED) are at particular risk of life-threatening hyperthermia during exercise in a warm environment. In this study, the effects of physical exercise are investigated in boys and male adolescents with X-chromosomally inherited HED as well as age-matched controls, who undergo standardized exertion on a bicycle ergometer at ambient temperatures of 25°C and 30°C. Body core temperature during and after ergometry, heart rate, performance, and serum lactate as a marker of metabolic stress are measured. Subjects with HED are expected to show an endangering rise of body temperature in connection with physical exercise. To clarify, whether novel cooling devices may reduce the likelihood of overheating, the effects of such devices are evaluated at 30°C.

02

Conditions studied

  • X-Linked Hypohidrotic Ectodermal Dysplasia
  • Exercise-induced Rise of Body Temperature

Keywords

  • hypohidrotic ectodermal dysplasia
  • exertional hyperthermia
  • cooling device
03

In context

Ectodermal Dysplasia 1, Anhidrotic

21 studies on the registry are indexed under Ectodermal Dysplasia 1, Anhidrotic; 1 is open to participants now.

This study's enrollment of 28 is below the median of 33 across 16 observational studies indexed under Ectodermal Dysplasia 1, Anhidrotic.

Browse Ectodermal Dysplasia 1, Anhidrotic studies →

Lead sponsor

University Hospital Erlangen is the lead sponsor of 28 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

subjects with X-chromosomally inherited hypohidrotic ectodermal dysplasia (HED) and age-matched controls

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • for patients: hypohidrotic ectodermal dysplasia caused by EDA gene mutations
  • regular fluid intake prior to the investigation
  • written

Exclusion criteria

Exclusion Criteria:

  • acute febrile illness
  • acute or chronic heart disease
  • arterial hypertension
  • gastrointestinal disorders
  • implantable electronic devices
  • MRI investigation scheduled for the 5 days subsequent to the study
  • clinical signs or diagnostic findings of dehydration
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
28 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • HED children
  • HED adolescents

    Device: Skin cooling devices

  • Control children
  • Control adolescents

    Device: Skin cooling devices

Interventions

  • DeviceSkin cooling devices

    Cooling vest and cooling bandana

    Also known as: Cooline

06

Study locations

1 site
  • University Hospital Erlangen
    Erlangen, Bavaria 91054, Germany
07

References and documents

Publications

  • Hammersen JE, Neukam V, Nusken KD, Schneider H. Systematic evaluation of exertional hyperthermia in children and adolescents with hypohidrotic ectodermal dysplasia: an observational study. Pediatr Res. 2011 Sep;70(3):297-301. doi: 10.1203/PDR.0b013e318227503b. PubMed 21646941 ↗
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2009, a primary completion of Feb 2010 and a completion of Feb 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2010
First posted
Jun 3, 2010
Start
Apr 2009
Primary completionActual
Feb 2010
CompletionActual
Feb 2010
Last update
Aug 19, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01135888
Lead sponsor
University Hospital Erlangen
Collaborators
Pervormance GmbH
Responsible party
Prof. Dr. Holm Schneider (Professor of Pediatrics, University Hospital Erlangen) — Principal investigator
First posted
Jun 3, 2010
Start date
Apr 2009
Primary completion
Feb 2010
Completion
Feb 2010
Last update
Aug 19, 2021

Study contacts

Holm Schneider, MD
principal investigator · University Hospital Erlangen

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion